All In MedTech

Device Trial Radar · NCT04804943

Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)

Pilot Clinical Study to Investigate the Efficacy and Safety of NOA-001 for the Treatment of Patients With Acute Respiratory Distress Syndrome.

Last checked: Nov 20, 2026Latest source record: Jul 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

45

Planned (sponsor's estimate)

Start

May 22, 2021

Primary completion

Jun 30, 2025

Study completion Sep 4, 2025

Sponsor

Lead sponsor
Toray Industries, IncNot on our public-company list
Sponsor type
Industry
First posted
Mar 18, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary object of this clinical study is to investigate the efficacy and the safety of NOA-001 in patients with ARDS (ARDS caused by Non-COVID-19 or COVID-19).

Conditions

  • Acute Respiratory Distress Syndrome

Interventions

  • NOA-001Device

    NOA-001 will be replaced regularly (at 22 to 24 hours after the initiation of procedure), and will be continuously performed until 168 hours from the enrollment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ventilator Free Days (VFD, Days alive and ventilator-free)Time frame: Day 28

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Showa University Hospital

    Tokyo, Japan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.